Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Bayer AG News Editors

News Widget

Display the Bayer AG news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Bayer AG News

News on Bayer AG (Ticker: BAYRY) continually updated from thousands of sources around the net.

Monday May 21 | Reuters

TEXT-Fitch revises Bayer's outlook to positive;afrms at 'A-'

May 21 - Fitch Ratings has revised the Outlook on Germany-based healthcare chemicals group Bayer AG's Long-term Issuer Default Rating to Positive from Stable and affirmed the IDR and senior unsecured ratings at 'A'-. The agency has also affirmed the Short-term IDR at 'F2' and Bayer's EUR1.3bn hybrid bond at 'BBB'. "The Positive Outlook reflects ... (more)

Comment?

Related Topix: Medicine, Aspirin (generic), Bayer, Alka-Seltzer, Medication, Manufacturing, Biotech, Bayer AG, Chemicals, Pharmaceuticals

Fri May 11, 2012

Business Journal

OncoMed files for $115 million IPO

The Redwood City-based cancer drug developer, one of the most successful Bay Area biotech companies at raising venture capital over the past five years, said it will use proceeds of the IPO to advance its lead drug -- demcizumab, or OMP-21M18 -- and two other drugs into Phase II clinical trials and for programs with partners GlaxoSmithKline and ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, GlaxoSmithKline, e-Spirit, Pharmaceuticals, Securities and Exchange Commission, Corporate / Securities Law, Law

Thu May 10, 2012

AmericanBankingNews.com

Societe Generale Now Covering Bayer AG

The firm set a "hold" rating on the stock. A number of other analysts have also recently weighed in on BAYRY.

Comment?

Related Topix: e-Spirit, Manufacturing, Biotech, Bayer AG, Pharmaceuticals, Chemicals

Sun May 06, 2012

India Gazette

Bayer challenges India cancer drug ruling favoring Natco

German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer.India's patents chief ruled in March the price Bayer charged for the drug, Nexavar, was "exorbitant" and ordered the firm to give a so-called "compulsory ... (more)

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, Pharmaceuticals

Tue May 01, 2012

AmericanBankingNews.com

Zacks Reiterates "Neutral" Rating on Bayer AG

's stock had its "neutral" rating reiterated by Zacks in a research note issued to investors on Tuesday.

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, e-Spirit, Pharmaceuticals

Mon Apr 30, 2012

Reuters

Warner Chilcott to explore alternatives

The company's announcement comes after chatter emerged of Bayer AG making a bid for the company at $32 per Warner Chilcott share.

Comment?

Related Topix: Biotech, Medicine, Warner Chilcott, Healthcare Industry, e-Spirit, Manufacturing, Bayer AG, Pharmaceuticals, Chemicals

Reuters

TEXT-S&P summary: Bayer AG

The ratings on Germany-based pharmaceuticals, polymers, and agrochemicals conglomerate Bayer AG reflect Standard & Poor's Ratings Services' view of the group's strong business risk profile.

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, e-Spirit, Pharmaceuticals

Los Angeles Jobs

Also on Topix